$Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed/Refractory Multiple Myeloma: Real World Evidence from Italy$
QR Code

QR Code

Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed/Refractory Multiple Myeloma: Real World Evidence from Italy

Valentina Perrone, Melania Leogrande, Elisa Giacomini, Maria Cappuccilli, Luca Degli Esposti On behalf of the LHU study groupCliCon S.R.L. Società Benefit, Health Economics and Outcomes Research, Bologna, ItalyCorrespondence: Valentina Perrone, CliCon S.R.L. Società Benefit - Health, Economics and O...

Full description

Saved in:

Bibliographic Details
Main Authors:	Perrone V, Leogrande M, Giacomini E, Cappuccilli M, Degli Esposti L
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-07-01
Series:	ClinicoEconomics and Outcomes Research
Subjects:	triplet combination therapy immunomodulatory agents proteasome inhibitors monoclonal antibodies duration of therapy treatment lines
Online Access:	https://www.dovepress.com/healthcare-costs-and-treatment-patterns-of-triplet-therapies-in-relaps-peer-reviewed-fulltext-article-CEOR
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Real-World Analysis of Patients with Triple Class Exposed Multiple Myeloma in Italy: Epidemiology Estimates, Treatment Pattern and Economic Burden
by: Valentina Perrone, et al.
Published: (2025-07-01)

Efficacy of IsaPomDex triplet therapy in double refractory multiple myeloma patients in real clinical practice in Russia
by: M. V. Solovev, et al.
Published: (2024-12-01)

Pomalidomide in relapsed and refractory multiple myeloma: multicenter retrospective study
by: V. G. Potapenko, et al.
Published: (2022-07-01)

Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma
by: Matthew J. Pianko, et al.
Published: (2025-12-01)

Pomalidomide for the management of relapsed and refractory multiple myeloma: a case report and review of literature
by: S. V. Semochkin
Published: (2015-10-01)

Optimizing Contrastive Learning with Semi-Online Triplet Mining
by: Przemysław Buczkowski, et al.
Published: (2025-07-01)

SPECTRUMS OF SUPERCONDUCTING STATES AND TRIPLET EFFECTS IN SUPERCONDUCTOR/FERROMAGNET MULTILAYERS
by: V. N. Kushnir
Published: (2019-12-01)

Biological basis of immunomodulatory preparations using in treatment of multiple myeloma
by: S. V. Semochkin
Published: (2022-11-01)

Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting
by: E. A. Pyadushkina, et al.
Published: (2021-07-01)

Augmented reality in developing students’ understanding of chemistry triplet: a systematic literature review
by: Ribič Luka, et al.
Published: (2024-12-01)

Polish digit triplet test for auditory screening: development and initial evaluation
by: Edward Ozimek, et al.
Published: (2014-01-01)

New Paradigm in Treating Cancer: Right on Target
by: Noorwati Sutandyo
Published: (2016-09-01)

New Paradigm in Treating Cancer: Right on Target
by: Noorwati Sutandyo
Published: (2016-09-01)

T-UNet: triplet UNet for change detection in high-resolution remote sensing images
by: Huan Zhong, et al.
Published: (2025-03-01)

EFFICIENCY OF SOME IMMUNOMODULATORY DRUGS FOR PREVENTION OF RESPIRATORY INFECTIONS AND THEIR COMPLICATIONS IN YOUNG SCHOOLCHILDREN WITH RECURRENT RESPIRATORY INFECTIONS
by: R. V. Maiorov, et al.
Published: (2014-07-01)

Dynamics of quality of life indicators at a multiple sclerosis
by: V. N. Karnaukh, et al.
Published: (2010-08-01)

Depletion-restitution therapy of autoimmune rheumatic diseases. Part 2. Perspectives on bispecific antibodies
by: A. L. Maslyanskiy, et al.
Published: (2025-06-01)

Depletion-restitution therapy for autoimmune rheumatic diseases. Part 1. Fundamental prerequisites and efficacy of modern treatment technologies: anti-B-cell drugs and CAR-T therapy
by: A. M. Lila, et al.
Published: (2025-04-01)

Results of multiple myeloma treatment with bortezomib
by: T. I. Pospelova, et al.
Published: (2022-11-01)

Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review
by: Hongjuan Dong, et al.
Published: (2025-07-01)

New proteasome inhibitors in the management of multiple myeloma
by: S. V. Semochkin
Published: (2019-07-01)

Perioperative outcomes of esophagectomy after doublet versus docetaxel‐based triplet neoadjuvant chemotherapy in older patients: A nationwide inpatient database study in Japan
by: Yuki Hirano, et al.
Published: (2025-07-01)

Improved multi-scale inverse bottleneck residual network based on triplet parallel attention for apple leaf disease identification
by: Lei Tang, et al.
Published: (2024-03-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

Comorbidities in patients with multiple myeloma
by: L. P. Kuznetsova, et al.
Published: (2019-08-01)

Purification of Monoclonal Antibodies Using Chromatographic Methods: Increasing Purity and Recovery
by: Elnazalsadat Jafarzadeh Chehraghi, et al.
Published: (2025-04-01)

THE INTRACELLULAR AND CIRCULATING POOLS OF PROTEASOMES: THE VALUE AT CANCER IN DIFFERENT LOCATIONS
by: E. E. Shashova, et al.
Published: (2016-02-01)

Photophysical Properties and Protein Binding Studies of Piperazine-Substituted Anthracene-BODIPY Dyads for Antimicrobial Photodynamic Therapy
by: Stephen O’Sullivan, et al.
Published: (2025-06-01)

DETERMINATION OF THE ACCEPTOR MOLECULES CONCENTRATION IN THE TRIPLET STATE ON EXCITATION OF DONOR-ACCEPTOR PAIRS BY RECURRENT PULSES
by: Natal’ya Vladimirovna Zhdanova, et al.
Published: (2022-09-01)

Clinical and immunological efficacy of immunotherapeutic program after surgical treatment of children with various forms of acute peritonitis
by: I. V. Nesterova, et al.
Published: (2022-07-01)

A CLINICAL CASE OF THE USE OF AN IMMUNOMODULATORY DRUG IN THE COMPLEX THERAPY OF SEVERE GENERALIZED PERIODONTITIS
by: G.М. Silenko, et al.
Published: (2020-12-01)

Proteasome activity and subunit composition in endometrial hyperplasia and cancer
by: L. V. Spirina, et al.
Published: (2014-08-01)

Cardiotoxicity of genetic engineered biological therapy in immuno-mediated and oncological diseases
by: V. A. Akhmedov, et al.
Published: (2024-04-01)

The effectiveness and safety of ofatumumab for the treatment of pemphigus vulgaris: a cohort study based on a registry database
by: Xiwen Zhang, et al.
Published: (2025-07-01)

Dynamics of cellular immunity indicators in the complex treatment of acute optic neuritis
by: D. A. Storozhilova, et al.
Published: (2023-06-01)

Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development
by: Tao Wang, et al.
Published: (2025-07-01)

Study on the monoclonal antibody to chlorpyrifos
by: JIN Ren-yao, et al.
Published: (2006-11-01)

MANUFACTURING OF HYBRIDOMAS-PRODUCERS OF MONOCLONAL ANTIBODIES TO BRUCELLOSIS AGENT ANTIGENS
by: G. V. Kuklina, et al.
Published: (2017-06-01)

Role of the ubiquitin-proteasome system in the progression of oral squamous cell carcinoma
by: D. E. Mikhalev, et al.
Published: (2021-07-01)

Unlocking Healing: Ozone Therapy’s Breakthrough in Oral Lesion Management – A Narrative Review
by: Nishath Sayed Abdul, et al.
Published: (2025-06-01)